Results 91 to 99 of about 99 (99)

Clinical Outcomes of Intensity Modulated Proton Therapy for Salivary Gland Carcinoma: High Local Control and Quality of Life Preservation

Head &Neck, EarlyView.
ABSTRACT Background In recent years, particle therapy has shown promise as a local treatment for salivary gland carcinoma (SGC); however, its efficacy and safety remain unclear. This study aimed to evaluate the clinical outcomes of intensity‐modulated proton therapy (IMPT) for SGC.
Gaku Takano, Daisuke Kawakita, Hiromitsu Iwata, Yukiko Hattori, Koichiro Nakajima, Yusuke Tsuzuki, Shuou Sudo, Toshiyuki Toshito, Kensuke Hayashi, Takuma Matoba, Michi Sawabe, Kiyoshi Minohara, Sho Iwaki, Kazuyuki Nakai, Yu Iwase, Shinichi Iwasaki, Hiroyuki Ogino   +16 more
wiley   +1 more source

Acoustic Features of Airway Protective Maneuvers as Biomarkers of Radiation‐Associated Dysphagia and Penetration/Aspiration in Head and Neck Cancer Patients

Head &Neck, EarlyView.
ABSTRACT Background This study aimed at identifying acoustic features of airway protective maneuvers as biomarkers of radiation‐associated dysphagia, involving penetration/aspiration and pharyngeal residue. Methods Temporal and spectral acoustical analyses were carried out on voluntary coughs, voluntary throat clearings, and reflexive coughs.
Sofiana Mootassim‐Billah, Jean Schoentgen, Marc De Bodt, Hichem Slama, Esther Willemse, Tatiana Dragan, Nicolas Roper, Mathilde Le Tensorer, Paulus Kristanto, Marianne Paesmans, Dirk Van Gestel, Gwen Van Nuffelen   +11 more
wiley   +1 more source

Multidimensional Prognostic Index as a Predictor of Mortality in Head and Neck Cancer Patients: A Cohort Study

Head &Neck, EarlyView.
ABSTRACT Background Head and neck cancer (HNC) significantly impacts older adults, with mortality influenced by multiple factors. The Multidimensional Prognostic Index (MPI), derived from comprehensive geriatric assessment (CGA), may improve risk stratification and clinical decision making. Methods An observational cohort study was conducted at Erasmus
Ajay T. Bakas, Aniel Sewnaik, Femke Flikweert, Robert Jan Baatenburg de Jong, Francesco Mattace‐Raso, Harmke Polinder‐Bos   +5 more
wiley   +1 more source

Direct Economic Burden of Post‐Cancer Treatment Pain Among Cancer Survivors in the United States: A Population‐Based Retrospective Longitudinal Study

The International Journal of Health Planning and Management, EarlyView.
ABSTRACT Purpose Post‐cancer treatment pain (PCTP) is prevalent among cancer survivors but remains understudied. It is critical to quantify PCTP prevalence over time and to estimate the resulting short and long‐term incremental healthcare expenditures (total, third‐party, and out‐of‐pocket) and out‐of‐pocket burden among cancer survivors.
Yves Paul Vincent Mbous, Rowida Mohamed, Uche Osahor, Traci J. LeMasters   +3 more
wiley   +1 more source

Nanotechnology in brain cancer treatment: The role of gold nanoparticles as therapeutic enhancers

Ibrain, EarlyView.
This review highlights the potential of gold nanoparticles (AuNPs) in overcoming the blood‐brain barrier (BBB) to improve brain tumor treatment. By enabling targeted drug delivery and enhancing therapies like radiotherapy, phototherapy, and chemotherapy, AuNPs offer a promising approach for safer, more effective treatments of glioblastoma and other ...
Simona Tarantino, Annalisa Bianco, Valeria De Matteis, Edoardo Scarpa, Rosaria Rinaldi   +4 more
wiley   +1 more source

Real‐world treatment patterns and outcomes based on RAS/BRAF status in metastatic colorectal cancer—Analysis of the Prospective Dutch Colorectal Cancer cohort

International Journal of Cancer, EarlyView.
What's New? The treatment landscape of metastatic colorectal cancer has evolved into a continuum of care with guideline recommendations depending on molecular status. However, guidelines are primarily based on the results of randomized clinical trials, which do not fully align with clinical practice.
Sietske C. M. W. van Nassau, Koen Zwart, Frederieke H. van der Baan, Geraldine R. Vink, Marloes A. G. Elferink, Petur Snaebjornsson, Anne M. May, Miriam Koopman, Jeanine M. L. Roodhart   +8 more
wiley   +1 more source

Factors associated with diagnostic and treatment intervals in colorectal cancer: A linked data study

International Journal of Cancer, EarlyView.
What's New? Colorectal cancer (CRC) is often diagnosed not by screening but because symptoms occur. Previous studies investigating the length of time between presentation and diagnosis have focused on patient characteristics, but here, the authors also look at how provider and health system factors contribute to longer diagnostic intervals, using an ...
Allison Drosdowsky, Karen E. Lamb, Luc te Marvelde, Peter Gibbs, Catherine Dunn, Ian Faragher, Ian Jones, Maarten J. IJzerman, Jon D. Emery   +8 more
wiley   +1 more source

Patient‐derived tumor organoids highlight the potential of precision medicine in managing pancreatic ductal adenocarcinoma

International Journal of Cancer, EarlyView.
What's New? Only about one‐fifth of patients with pancreatic ductal adenocarcinoma (PDAC) qualify for curative treatment approaches employing adjuvant chemotherapy. Tools to predict PDAC response to chemotherapeutic regimens, however, are lacking.
Christine Nitschke, Charline Phan, Yara Souto, Philipp Walter, Mara Goetz, Gediminas Simkus, Jacob Thastrup, Ronald Simon, Jürgen Kupper, Jakob Izbicki, Steven A. Johnsen, Thilo Hackert, Marianne Sinn, Harriet Wikman, Faik G. Uzunoglu, Tabea M. Sturmheit   +15 more
wiley   +1 more source

Multifactorial construction of low‐grade and high‐grade endometrial cancer recurrence prediction models

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To analyze independent risk factors for endometrial cancer (EC), a common female cancer globally, and construct individualized prediction models for EC recurrence. Methods The EC patients from the medical record system were divided into low‐grade (n = 392) and high‐grade (n = 183) groups.
Yachai Li, Jia Yan, Yuanmei Deng, Peixuan Wang, Xue Bai, Wei Qin   +5 more
wiley   +1 more source